SCHEMBL30299371

SCHEMBL30299371

CN1CCN(c2ccc(C3(N)N=C(N)NN3)cc2F)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 4/20 0.38
MAPT P10636 4/20 0.37
POLB P06746 1/20 0.37
RAD52 P43351 1/20 0.37
NCF1 P14598 1/20 0.36
MAPK1 P28482 2/20 0.36
AXL P30530 2/20 0.36
LMNA P02545 1/20 0.36
GFER P55789 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
PTK2B Q14289 1/20 0.35
ADRA2C P18825 1/20 0.35
HRH4 Q9H3N8 2/20 0.34
HSD17B10 Q99714 1/20 0.34
WDR5 P61964 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30090486 0.90 KCNH2 (0.39) ALDH1A1L3MBTL1AXLFLT3
SCHEMBL30299377 0.85 PDE3B (0.34) ALDH1A1MAPTMAPK1LMNAGFER
SCHEMBL29929506 0.83 ALDH1A1 (0.33) ALDH1A1MAPTMAPK1AXLLMNA
SCHEMBL30090537 0.83 TNIK (0.36) GAA
SCHEMBL30299369 0.83 AXL (0.37) ALDH1A1KDM4EMAPTMAPK1AXL
SCHEMBL30299303 0.82 CYP17A1 (0.36) ALDH1A1MAPTMAPK1LMNAGFER
SCHEMBL30090687 0.82 AXL (0.38) ALDH1A1KDM4EMAPTMAPK1AXL
SCHEMBL29929683 0.81 AXL (0.40) ALDH1A1L3MBTL1AXLLMNA
SCHEMBL30299368 0.81 GAA (0.38) ALDH1A1KDM4EMAPTPOLBMAPK1
SCHEMBL29928107 0.80 MAPT (0.49) ALDH1A1KDM4EMAPTNCF1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116075303-A Method of selecting patients treated with a combination of an AXL inhibitor and an immune checkpoint modulator 卑尔根生物股份公司 2023-05-05 CN disclosed
CN-115916344-A AXL inhibitors for antiviral therapy 卑尔根生物股份公司 2023-04-04 CN disclosed